Table 1

Patterns of CRBPI promoter hypermethylation in human cancer according to the prevalence of the alteration

Lymphoma60% (39/65)
Colon57% (101/177)
Gastric42% (8/19)
Liver30% (10/33)
Leukemia28% (15/53)
Breast19% (9/48)
Bladder18% (5/27)
Lung15% (6/41)
Glioma14% (3/21)
Head and neck7% (1/15)
Ovary0% (0/21)
Endometrial0% (0/33)
Total: 553 primary tumors